Accendra Health Inc ACH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Accendra Health Reports Third Quarter 2026 Financial Results
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
Trading Information
- Previous Close Price
- $0.30
- Day Range
- $0.20–0.25
- 52-Week Range
- $0.19–4.69
- Bid/Ask
- $0.21 / $0.22
- Shares Outstanding
- 76.90M
- Market Cap
- $15.62M
- Volume/Avg
- 3M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 0.88
- Price/Sales
- 0.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 22.56%
Company Profile
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 6,500
Valuation
Metric | ACH |
|---|---|
Price/Earnings (Normalized) | 0.88 |
Price/Book Value | — |
Price/Sales | 0.01 |
Price/Cash Flow | 0.49 |
Price/Earnings
ACH
Financial Strength
Metric | ACH |
|---|---|
Quick Ratio | 0.20 |
Current Ratio | 0.41 |
Interest Coverage | −0.12 |
Quick Ratio
ACH
Profitability
Metric | ACH |
|---|---|
Return on Assets (Normalized) | −2.90% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 2.20% |
Return on Assets
ACH
Medical Distribution Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| McKesson Corp MCK | LOCK|M@$qZ# | LOCK|!f%$% | $122B | |||
| Cencora Inc COR | LOCK|f>%<#LD | LOCK|Q?#g? | $64B | |||
| Cardinal Health Inc CAH | LOCK|txCH<q | LOCK|?<dys | $63B | |||
| Sigma Healthcare Ltd SIGGF | — | LOCK|<xYsl | $23B | |||
| Henry Schein Inc HSIC | LOCK|>kR@^L | LOCK|znzMq | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY | — | LOCK|&< | $8B | |||
| Sinopharm Group Co Ltd SHTDF | — | LOCK|pk& | $7B | |||
| Sinopharm Group Co Ltd ADR SHTDY | — | LOCK|l$P | $7B | |||
| Galenica Ltd GALNF | — | LOCK|@CN># | $5B | |||
| Medipal Holdings Corp MEPDF | — | LOCK|k< | $4B |
United States